Abstract
Repeated treatment of mice with lithium chloride (45 mg/kg, i.p., daily for 8 days) reduced the jumping, fighting, stereotypies, and hyperactivity induced by d-amphetamine (5 mg/kg, i.p.). Lithium also reduced the hypoactivity observed 1–3 h after reserpine (0.75 mg/kg, i.p.). In biochemical studies we found that 8-day treatment with lithium markedly reduced (to 45% of control) the recovery from brain of labelled 2-phenylethylamine (PEA) following i.p. injection of labelled L-phenylalanine, while decreasing recovery from brain of labelled PEA following its i.p. injection to 63% of control. In saline-treated mice, d-amphetamine appeared to increase PEA synthesis and to accelerate its disposition, whereas reserpine enhanced PEA synthesis and reduced disposition; all of these effects were antagonized by lithium pretreatments. Since PEA appears to be one of the most powerful behavioral stimulants among endogenous neuroamines, and because its deaminated metabolites are behavioral depressants, such antagonism of brain PEA metabolism may significantly contribute to the prophylactic action of lithium against both manic and depressive behavior.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baldessarini, R. J., Yorke, C.: Effects of lithium and of pH on synaptosomal metabolism of noradrenaline. Nature (London) 228, 1301–1303 (1970)
Borison, R. L., Lemus, F., Reyes, M., Havdala, H. S., Diamond, B. I.: Regional localization of 2-phenylethylamine in human brain. Res. Commun. Psychol. Behav. 2, 193–201 (1977)
Borison, R. L., Mosnaim, A. D., Sabelli, H. C.: Biosynthesis of brain 2-phenylethylamine: Influence of decarboxylase inhibition and d-amphetamine. Life Sci. 15, 1837–1848 (1974)
Borison, R. L., Mosnaim, A. D., Sabelli, H. C.: Brain 2-phenylethylamine as a major mediator for the central actions of amphetamine and methylphenidate. Life Sci. 17, 1331–1344 (1975)
Davis, J. M.: Overview: maintenance therapy in psychiatry. II. Affective disorders. Am. J. Psychiatry 133, 1–13 (1976)
Fischer, E., Heller, B., Nachon, M., Spatz, H.: Therapy of depression by phenylalanine. Arzneim. Forsch. 25, 132 (1975)
Fischer, E., Heller, B., Spatz, H., Reggiani, H.: Phenylethylamine content of human urine and rat brain, its alterations in pathological conditions and after drug administration. Experientia 28, 307–308 (1972)
Fischer, E., Ludmer, R. I., Sabelli, H. C.: The antagonism of phenylethylamine to catecholamines in mouse motor activity. Acta Physiol. Lat. Am. 17, 15–21 (1967)
Giardina, W. J., Sabelli, H. C.: Evidence for the biological activity of the deaminated metabolites of the adrenergic amines. Biol. Psychiatry 9, 11–23 (1974)
Mosnaim, A. D., Inwang, E. E., Sabelli, H. C.: The influence of psychotropic drugs on the levels of endogenous 2-phenylethylamine in rabbit brain. Biol. Psychiatry 8, 227–234 (1974)
Sabelli, H. C., Borison, R. L.: Noncatecholaminic adrenergic modulators. In: Advances in biochemical psychopharmacology, vol. 15: First and second messengers — new vistas, E. Costa, E. Giacobini, and R. Paoletti, eds., pp. 75–86. New York: Raven 1976
Sabelli, H. C., Giardina, W. J.: Amine modulation of affective behavior. In: Chemical modulation of brain function, H. C. Sabelli, ed., pp. 225–259. New York: Raven 1973
Sabelli, H. C., Mosnaim, A. D.: Phenylethylamine hypothesis of affective behavior. Am. J. Psychiatry 131, 695–698 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Borison, R.L., Sabelli, H.C., Maple, P.J. et al. Lithium prevention of amphetamine-induced ‘manic’ excitement and of reserpine-induced ‘depression’ in mice: Possible role of 2-phenylethylamine. Psychopharmacology 59, 259–262 (1978). https://doi.org/10.1007/BF00426631
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00426631